Aim: Spontaneous intracranial hemorrhage (SICH) in children is relatively less common as compared to adults, and there are limited studies addressing this issue in children. In this study, we analyze the etiology, clinical features, treatment options and outcome assessment in this population. Material and Methods: Fifty consecutive patients of spontaneous intracerebral bleed, aged 18 years and below, were retrospectively analyzed based on medical records and radiographic images. Status of the patient at the final follow-up after discharge was considered as the outcome. Results: Age of patients ranged from 2 months to 17 years with higher predilection in males (M:F = 3:2). Presenting features were symptoms of raised intracranial pressure (70.0%), deterioration in sensorium (50.0%), limb weakness (36.0%) and seizures (28%). Arteriovenous malformation (AVM) was the most common cause of hemorrhage, and was found in 22 patients (44%), followed by cerebral aneurysm in 17 cases (34%), moyamoya disease in 3 cases (6%), and intracranial tumor, hematological disorders and unknown cause (possible vasculitis) were each found in 2 patients (4%). Treatment modalities consisted of: excision of AVM, aneurysm clipping, embolization, superficial temporal artery to middle cerebral artery bypass, tumor excision, hematoma evacuation and conservative management. Thirty-five patients (74%) had good outcome and 13 patients had poor outcome (26%). Conclusions: Aneurysm is an important cause of SICH, alongside AVM, which is the leading cause. Thorough investigation is necessary to elucidate the cause of bleed, which may otherwise be missed. Cerebellar bleed and late presentation were found to be associated with poor outcome. Age was not found to be associated with outcome.

Keywords:
Spontaneous intracranial bleed, childhood, Spontaneous intracranial hemorrhage, pediatric, Hemorrhagic stroke
1.
Levene MI, Gaskill SJ, Marlin AE: Intracranial hemorrhage in the newborn; in Choux M, di Rocco C, Hockley AD, Walker ML (eds): Textbook of Pediatric Neurosurgery, ed 2. Heidelberg, Springer-Verlag, 1999, pp 653–663.
2.
Mottolese C, Hermier M, Stan H, Jouvet A, Saint-Pierre G, Froment JC, et al: Central nervous system cavernomas in the pediatric age group. Neurosurg Rev 2001;24:55–71.
3.
Mori K, Murata T, Hashimoto N, Handa H: Clinical analysis of arteriovenous malformations in children. Child Brain 1980;6:13–25.
4.
Spetzler RF, Martin NA: A proposed grading system of arteriovenous malformations. J Neurosurg 1986;65:476–483.
5.
Craig WS: Intracranial hemorrhage in the newborn. Arch Dis Child 1938;13:89–124.
6.
Fenichel GM, Webster DL, Wong WKT: Intracranial hemorrhage in the term newborn. Arch Neurol 1984;41:30–34.
7.
Fullerton HJ, Wu YW, Zhao S, Johnston SC: Risk of stroke in children: ethnic and gender disparities. Neurology 2003;61:189–194.
8.
Al-Jarallah A, Al-Rifai MT, Riela AR, Roach ES: Nontraumatic brain hemorrhage in children: etiology and presentation. J Child Neurol 2000;5:284–289.
9.
Meyer-Heim AD, Boltshauser E: Spontaneous intracranial hemorrhage in children: aetiology, presentation and outcome. Brain Dev 2003;25:416–421.
10.
Chung B, Wong V: Pediatric stroke among Hong Kong Chinese subjects. Pediatrics 2004;114:e206–e212.
11.
Giroud M, Lemesle M, Madinier G, Manceau E, Osseby GV, Dumas R: Stroke in children under 16 years of age: clinical and etiological difference with adults. Acta Neurol Scand 1997;96:401–406.
12.
Livingston JH, Brown JK: Intracerebral haemorrhage after the neonatal period. Arch Dis Child 1986;61:538–544.
13.
Beran-Koehn, Brown RD, Mellinger JF, Christianson TJ, O’Fallon WM: Cerebrovascular disease in children: incidence, etiology and outcome. Neurology 1999;52(suppl 2):A43–A44.
14.
Blom I, De Schryver EL, Kappelle LJ, Rinkel GJ, Jennekens-Schinkel A, Peters AC: Prognosis of hemorrhagic stroke in childhood: a long-term follow-up study. Dev Med Child Neurol 2003;45:233–239.
15.
Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G: Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000;54:371–378.
16.
Zahuranec DB, Brown DL, Lisabeth LD, Morgenstern LB: Is it time for a large, collaborative study of pediatric stroke? Stroke 2005;36:1825–1829.
17.
Broderick J, Talbot GT, Prenger E, Leach A, Brott T: Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993;8:250–255.
18.
Brown RD, Wiebers DO, Torner JC, O’Fallon WM: Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population base study of intracranial vascular malformation in Olmsted County, Minnesota. J Neurosurg 1996;85:29–32.
19.
Gerosa MA, Cappellotto P, Licata C, Iraci G, Pardatscher K, Fiore DL: Cerebral arteriovenous malformations in children (56 cases). Childs Brain 1981;8:356–371.
20.
Crawford PM, West CR, Chadwick G: Cerebral ateriovenous malformations in children: clinical features and outcome in treatment in children and in adults. Surg Neurol 1984;22:43–49.
21.
Jomin M, Lesion F, Lozes G: Prognosis for arteriovenous malformations of the brain in adults based on 150 cases. Surg Neurol 1985;23:362–366.
22.
Heros RC, Korosue K, Diebold PM: Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery 1990;26:570–578.
23.
El-Gohary EM, Tomita T, Gutierrez FA, McLone DC: Angiographically occult vascular malformation in childhood. Neurosurgery 1987;20:759–766.
24.
Celli P, Ferrante L, Palma L, Cavedon G: Cerebral arteriovenous malformations in children: clinical features and outcome of treatment in children and in adults. Surg Neurol 1984;22:43–39.
25.
Fong D, Chan S: Arteriovenous malformation in children. Childs Nerv Syst 1988;4:199–203.
26.
Humphreys RP, Hoffman HJ, Drake JM, Rutka JT: Choices in the 1990s for the management of pediatric cerebral arteriovenous malformations. Pediatric Neurosurg 1996;25:277–285.
27.
Garza-Mercado R, Cavazos E, Tamez-Montes D: Cerebral arteriovenous malformations in children and adolescents. Surg Neurol 1987;27:131–140.
28.
Kondizolka D, Humphreys RP, Hoffman HJ, Hendrick BE, Drake JM: Arteriovenous malformations of the brain in children: a forty year experience. Can J Neurol Sci 1992;19:40–45.
29.
Millar C, Bissonnette B, Humphreys RP: Cerebral arteriovenous malformations in children. Can J Anaesth 1994;41:321–331.
30.
Delitala A, Delfini R, Vagnozzi R, Esposito S: Increase in size of cerebral angiomas (case report). J Neurosurg 1982;57:556–558.
31.
Graf CJ, Perret GE, Torner JC: Bleeding from arteriovenous malformations as part of natural history. J Neurosurg 1983;58:331–371.
32.
Ostergaard JR: Association of intracranial aneurysm and arteriovenous malformations in children. Neurosurgery 1984;14:358–362.
33.
Gerosa M, Licata C, Fiore DL, et al: Intracranial aneurysms in childhood. Childs Brain 1980;6:295–302.
34.
Meyer FB, Sundt TMJ, Fode ND, et al: Cerebral aneurysms in childhood and adolescence. J Neurosurg 1989;70:420–425.
35.
Heiskanen O, Vilkki J: Intracranial arterial aneurysms in children and adolescents. Acta Neurochir (Wien) 1981;59:55–63.
36.
Alemeida GM, Pindaro J, Plese R, Bianco E, Shibata MK: Intracranial arterial aneurysms in infancy and childhood. Childs Brain 1977;3:193–199.
37.
Humphreys RP, Hendrick EB, Hoffman HJ, Storrs BB: Childhood aneurysms – atypical features, atypical management. Concepts Pediatr Neurosurg 1985;6:213–219.
38.
Ostergard JR, Voldby B: Intracranial aneurysms in childhood and adolescents. J Neurosurgery 1983;58:832–837.
39.
Schoenberg BS, Mellinger JF, Schoenberg DG: Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology 1978;28:763–768.
40.
Lin CL, Loh JK, Kwan AL, Howng SL: Spontaneous intracerebral hemorrhage in children. Kaohsiung J Med Sci 1999;15:146–151.
41.
Lussenhop AJ, Rosa L: Cerebral arteriovenous malformations: indications for and results of surgery, and the role of intravascular techniques. J Neurosurg 1984;60:14–22.
42.
Frizzel RT, Fisher WS III: Cure, morbidity and mortality associated with embolisation of brain arteriovenous malformations: a review of 1,246 patients in 32 series over a 35-year period. Neurosurgery 1995;37:1031–1040.
43.
Wikholm G, Lundqvist C, Svendsen P: Embolization of cerebral arteriovenous malformations. I. Technique, morphology and complications. Neurosurgery 1996;39:448–457, discussion 457–459.
44.
Wikholm G, Lundqvist C, Svendsen P: Embolization of cerebral arteriovenous malformations. II. Aspects of complications and late outcome. Neurosurgery 1996;39:460–467, discussion 467–469.
45.
Picard L, Moret J, Lepoire J: Endovascular treatment of intracranial arteriovenous angiomas: techniques, indications and results. J Neuroradiol 1984:11:9–28.
46.
Wolpert SM, Barnett FJ, Prager RJ: Benefits of emoblization without surgery for cerebral arteriovenous malformations. AJNR 1981;2:535–538.
47.
Levy RP, Fabrikant JI, Frankel KA, et al: Stereotactic heavy-charged particle Bragg peak radiosurgery for the treatment of intracranial arteriovenous malformations in childhood and adolescence. Neurosurgery 1984;24:841–852.
48.
Yamamoto M, Jimbo M, Ide M, Tanaka N, Lindquist C, Steiner L: Long-term follow-up of radiosurgically treated arteriovenous malformations in children: report of nine cases. Surg Neurol 1992;38:95–100.
49.
Colombo F, Benedetti A, Pozza F, Marchetti C, Chierego G: Linear accelerator radiosurgery of cerebral arteriovenous malformations. Neurosurgery 1989;24:833–840.
50.
Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G: Volume of intracranial hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24:987–993.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.